Catalent is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals. Catalent also provides contract development and manufacturing services to more than 125 clients worldwide.

Catalent roots can be traced to FH Faulding and Co, for many years one of the largest and most prominent public companies headquartered in South Australia.

Catalent’s Greenville, N.C. facility specializes in end-to-end turn-key solutions for oral solid dosage forms, including integrated formulation development, analytical services, commercial manufacturing, and packaging. This state-of-the-art facility has had over $100M of investments in recent years and features fit-for-scale capacity with potent handling capabilities, ideal for orphan or targeted drug development.

Located on Sugg Parkway in Greenville, NC